Lista de obras - Monica Bertagnolli - Dominio Público Uruguay

Advantages of a Truly Open-Access Data-Sharing Model

artículo científico publicado en 2017

Amputation for Extremity Sarcoma: Contemporary Indications and Outcomes

artículo científico publicado en 2017

Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803

artículo científico publicado en 2013

Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

artículo científico publicado en 2008

BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells

artículo científico publicado en 2009

Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.

artículo científico publicado en 2013

C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment ⬇️

artículo científico publicado el 1 de agosto de 2011

Cancer and leukemia group B gastrointestinal cancer committee

artículo científico publicado en 2006

Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis

artículo científico publicado en 2008

Celecoxib for the prevention of sporadic colorectal adenomas

artículo científico publicado en 2006

Celecoxib pathways: pharmacokinetics and pharmacodynamics

artículo científico publicado en 2012

Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back

artículo científico publicado en 2007

Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis

artículo científico publicado en 2010

Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

artículo científico publicado en 2020

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol

artículo científico publicado en 2008

Cox-2 and cancer chemoprevention: picking up the pieces

artículo científico publicado en 2007

CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.

artículo científico publicado en 2014

Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate

artículo científico publicado en 2009

Deficient E-cadherin adhesion in C57BL/6J-Min/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility

scientific journal article

Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.

artículo científico publicado en 2014

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

artículo científico publicado en 2016

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581

artículo científico publicado en 2011

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

artículo científico publicado en 2006

Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century"

artículo científico publicado en 2014

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial

artículo científico publicado en 2009

Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.

artículo científico publicado en 2004

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

scientific article published on 21 September 2020

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study

artículo científico publicado en 2013

Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma

artículo científico publicado en 2017

KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation

artículo científico publicado en 2014

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

artículo científico publicado en 2009

Leiomyosarcoma of the inferior vena cava: survival after aggressive management

artículo científico publicado en 2007

Locoregional Recurrence After Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Adverse Impact of Multifocal Disease and Potential Implications of Dose Escalation ⬇️

artículo científico publicado el 8 de febrero de 2013

MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial

artículo científico publicado en 2014

Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.

artículo científico publicado en 2011

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

scientific article published on 09 March 2009

Molecular origins of cancer: Molecular basis of colorectal cancer

artículo científico publicado en 2009

Much of the Genetic Risk of Colorectal Cancer Is Likely to Be Mediated Through Susceptibility to Adenomas ⬇️

artículo científico publicado el 19 de septiembre de 2012

Multimodality treatment of mesenteric desmoid tumours

artículo científico publicado en 2008

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803

artículo científico publicado en 2011

Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface

artículo científico publicado en 2012

Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery

artículo científico publicado en 2013

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

artículo científico publicado en 2010

Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)

artículo científico publicado en 2013

Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy

artículo científico publicado en 2013

Rejoinder

scientific article published on 08 April 2020

Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.

artículo científico publicado en 2011

Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas

artículo científico publicado en 2014

Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial

artículo científico publicado en 2010

Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection

artículo científico publicado en 2017

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors

artículo científico publicado en 2006

Surgical prevention of cancer

artículo científico publicado en 2005

The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma ⬇️

artículo científico publicado el 26 de octubre de 2011

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

artículo científico publicado en 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

artículo científico publicado en 2016

The electronic health record as a clinical trials tool: Opportunities and challenges

artículo científico publicado en 2020

The potential of non‐steroidal anti‐inflammatory drugs (NSAIDs) for colorectal cancer prevention ⬇️

artículo científico publicado el 1 de noviembre de 2003

What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report

scientific article published on 24 September 2020

p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.

artículo científico publicado en 2009

Lista de obras de Monica Bertagnolli

Advantages of a Truly Open-Access Data-Sharing Model

Amputation for Extremity Sarcoma: Contemporary Indications and Outcomes

Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803

Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells

Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.

C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment ⬇️

Cancer and leukemia group B gastrointestinal cancer committee

Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis

Celecoxib for the prevention of sporadic colorectal adenomas

Celecoxib pathways: pharmacokinetics and pharmacodynamics

Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back

Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis

Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol

Cox-2 and cancer chemoprevention: picking up the pieces

CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.

Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate

Deficient E-cadherin adhesion in C57BL/6J-Min/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility

Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century"

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial

Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study

Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma

KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

Leiomyosarcoma of the inferior vena cava: survival after aggressive management

Locoregional Recurrence After Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Adverse Impact of Multifocal Disease and Potential Implications of Dose Escalation ⬇️

MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial

Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

Molecular origins of cancer: Molecular basis of colorectal cancer

Much of the Genetic Risk of Colorectal Cancer Is Likely to Be Mediated Through Susceptibility to Adenomas ⬇️

Multimodality treatment of mesenteric desmoid tumours

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803

Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface

Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)

Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy

Rejoinder

Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.

Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas

Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial

Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors

Surgical prevention of cancer

The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma ⬇️

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

The electronic health record as a clinical trials tool: Opportunities and challenges

The potential of non‐steroidal anti‐inflammatory drugs (NSAIDs) for colorectal cancer prevention ⬇️

What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report

p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.